Mechanism of action of ginsenoside Rg_2 on diabetic retinopathy and angiogenesis based on YAP/TLRs pathway.
10.19540/j.cnki.cjcmm.20241216.302
- Author:
Zhuo-Rong LIU
1
;
Yong-Li SONG
1
;
Shang-Qiu NING
2
;
Yue-Ying YUAN
1
;
Yu-Ting ZHANG
1
;
Gai-Mei HAO
3
;
Jing HAN
1
Author Information
1. Beijing University of Chinese Medicine Beijing 102488, China.
2. Beijing Anzhen Hospital, Capital Medical University Beijing 100020, China.
3. Institute of Basic Theory for Chinese Medicine, China Academy of Chinese Medical Sciences Beijing 100700, China.
- Publication Type:Journal Article
- Keywords:
Toll-like receptors;
Yes-associatedprotein;
angiogenesis;
diabetic retinopathy;
ginsenoside Rg_2
- MeSH:
Animals;
Ginsenosides/pharmacology*;
Diabetic Retinopathy/physiopathology*;
Mice;
YAP-Signaling Proteins;
Humans;
Male;
Signal Transduction/drug effects*;
Cell Movement/drug effects*;
Adaptor Proteins, Signal Transducing/genetics*;
Mice, Inbred C57BL;
Neovascularization, Pathologic/metabolism*;
Drugs, Chinese Herbal/administration & dosage*;
Panax notoginseng/chemistry*;
Endothelial Cells/metabolism*;
Transcription Factors/genetics*;
Angiogenesis
- From:
China Journal of Chinese Materia Medica
2025;50(6):1659-1669
- CountryChina
- Language:Chinese
-
Abstract:
Ginsenoside Rg_2(GRg2) is a triterpenoid compound found in Panax notoginseng. This study explored its effects and mechanisms on diabetic retinopathy and angiogenesis. The study employed endothelial cell models induced by glucose or vascular endothelial growth factor(VEGF), the chorioallantoic membrane(CAM) model, the oxygen-induced retinopathy(OIR) mouse model, and the db/db mouse model to evaluate the therapeutic effects of GRg2 on diabetic retinopathy and angiogenesis. Transwell assays and endothelial tube formation experiments were conducted to assess cell migration and tube formation, while vascular area measurements were applied to detect angiogenesis. The impact of GRg2 on the retinal structure and function of db/db mice was evaluated through retinal thickness and electroretinogram(ERG) analyses. The study investigated the mechanisms of GRg2 by analyzing the activation of Yes-associated protein(YAP) and Toll-like receptors(TLRs) pathways. The results indicated that GRg2 significantly reduced cell migration numbers and tube formation lengths in vitro. In the CAM model, GRg2 exhibited a dose-dependent decrease in the vascular area ratio. In the OIR model, GRg2 notably decreased the avascular and neovascular areas, ameliorating retinal structural disarray. In the db/db mouse model, GRg2 increased the total retinal thickness and enhanced the amplitudes of the a-wave, b-wave, and oscillatory potentials(OPs) in the ERG, improving retinal structural disarray. Transcriptomic analysis revealed that the TLR signaling pathway was significantly down-regulated following YAP knockdown, with PCR results consistent with the transcriptome sequencing findings. Concurrently, GRg2 downregulated the expression of Toll-like receptor 4(TLR4), TNF receptor-associated factor 6(TRAF6), and nuclear factor-kappaB(NF-κB) proteins in high-glucose-induced endothelial cells. Collectively, GRg2 inhibits cell migration and tube formation and significantly reduces angiogenesis in CAM and OIR models, improving retinal structure and function in db/db mice, with its pharmacological mechanism likely involving the down-regulation of YAP expression.
